1. < Home

hydroxychloroquine

Autoimmune-Associated Livedoid Vasculopathy: Response to Immunomodulatory Therapy

Aung T, Cheah JX. Autoimmune-Associated Livedoid Vasculopathy: Response to Immunomodulatory Therapy. Cureus. 2025 Sep 19;17(9):e92748. doi: 10.7759/cureus.92748. PMID: 41122575; PMCID: PMC12535920.

By afschroeder • October 22, 2025
Nine-Year Follow-Up of GAD65 Antibody Limbic Encephalitis With Clinical Remission Despite Persistent Imaging and Serological Abnormalities

Aung T, Plotkin BE. Nine-Year Follow-Up of GAD65 Antibody Limbic Encephalitis With Clinical Remission Despite Persistent Imaging and Serological Abnormalities. Cureus. 2025 Jun 10;17(6):e85726. doi:[...]

By afschroeder • July 11, 2025
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort

Bellando-Randone S, Wilhalme H, Bruni C, Czirjak L, Distler O, Allanore Y, Cuomo G, Denton C, Del Galdo F, Gheorghiu AM, Riccieri V, Walker U,[...]

By sjmartinez • March 28, 2025
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)

Naggie S, Milstone A, Castro M, Collins SP, Lakshmi S, Anderson DJ, Cahuayme-Zuniga L, Turner KB, Cohen LW, Currier J, Fraulo E, Friedland A, Garg[...]

By sjmartinez • March 22, 2023
Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19

Kumbhakar R, Neradilek M, Barnabas RV, Stewart J, Stankiewicz Karita HC, Landovitz RJ, Kissinger PJ, Jerome KR, Paasche-Orlow MK, Bershteyn A, Chu HY, Neuzil KM,[...]

By sjmartinez • October 18, 2022